Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

Tabrizi, Sarah J, Prof ; Reilmann, Ralf, MD ; Roos, Raymund AC, MD ; Durr, Alexandra, MD ; Leavitt, Blair, FRCP ; Owen, Gail, PhD ; Jones, Rebecca, MSc ; Johnson, Hans, PhD ; Craufurd, David, FRCPsych ; Hicks, Stephen L, PhD ; Kennard, Christopher, FRCP ; Landwehrmeyer, Bernhard, MD ; Stout, Julie C, PhD ; Borowsky, Beth, PhD ; Scahill, Rachael I, PhD ; Frost, Chris, MA ; Langbehn, Douglas R, PhD

Lancet neurology, 2012, Vol.11 (1), p.42-53 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível